Insight brief
IQVIA Vigilance Detect Insight Brief
PV Technology and domain expertise, together realizing results. Innovations in PV AE monitoring are cutting costs and lowering risks, but not through technology solutions alone.
Jun 16, 2021
  • Library
  • IQVIA Vigilance Detect Insight Brief
To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.
What do biopharma and medical device companies do when faced with an increase in adverse event (AE) reports and product quality complaints (PQCs) from a rising number of sources, languages, and formats? For years the only answer was to implement overtime and hire more people to handle the overflow of tasks.

You may also be interested in

Scientific Poster
Evaluating consistencies in measuring patient’s HRQoL between head and neck cancer and multiple myeloma
Scientific Poster
Leveling up RWE adoption by US payers: The path towards optimizing its use in drug value assessments
Scientific Poster
Pricing and Market Access Posters
Scientific Poster
Panel-based tumor mutational burden (TMB) analysis of matched tumor and plasma specimens using Illumina's TruSight Oncology 500 next-generation sequencing assay
Scientific Poster
IQVIA publications in ASCO21 virtual science program
Scientific Poster
Identifying Undiagnosed Patients with Hepatitis C
Prev
Next

Related solutions

IQVIA Vigilance Platform

IQVIA Vigilance Platform is our secure SaaS environment built to simplify safety and PV processes, while boosting speed, accuracy, and efficiency.

IQVIA Vigilance Case

Vigilance Case provides real-time management, oversight and reporting of Safety cases, streamlining operations by automating low value activities.

IQVIA Vigilance Collect

IQVIA Vigilance Collect is a web and mobile app for receiving adverse events, allowing patients, HCPs, pharmacies, patient support programs and medical representatives to report adverse events in a user-friendly way.

Contact Us